Politics Dilute Germany’s AMNOG Updates: Impact On Pharma Firms
Executive Summary
New updates to Germany’s 2011 AMNOG healthcare reform act could lead to more conservative prescribing and benefit assessments for older products. Pricing measures were dropped but will likely resurface after September’s general elections.